NYSE · MOG.B

MOOG Inc. CL B

$403.32 +$7.60 (+1.92%) 1D Market open
Charting by TradingView

Key Metrics

$12.78B
Market cap
44.55×
P/E · TTM
$4.17B
Revenue · TTM
$286.85M
Net income
EPS · TTM $8.94
Dividend yield 0.3%
Free cash flow $310.25M
Beta · 1Y —
EBITDA · TTM $466.46M
Gross margin 27.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 9
    The stock moved +18.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 9
  • Jun 5
    The stock moved -14.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$12.78B
Enterprise value$13.71B
Shares outstanding31.7M
52-wk range$188.86 – $430.54
Avg volume · 20D617
Net cash −$932.27M
Book value / share$65.55
IndustryMisc Industrial & Commercial Machinery & Equipment
ExchangeNYSE
About MOOG Inc. CL B
IPO dateJan 4, 1996
Employees13500

Moog Inc. manufactures precision motion and fluid control systems for aerospace, defense, and industrial markets. Its four segments are Space and Defense, Military Aircraft, Commercial Aircraft, and Industrial, with the majority of revenue from Space and Defense.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E44.55
P/S3.07
P/FCF41.19
EV/EBITDA29.39
EV/Sales3.29
Graham №$114.86

Profitability

Gross 27.4%
Operating 9.1%
Net 6.9%
FCF 7.4%
ROE / ROIC 14.5% · 9.5%

Financial Health

Current ratio1.68
Quick ratio1.12
Debt / equity0.59
Debt / EBITDA 2.66
Net cash −$932.27M
Working capital$1.13B

Cash Flow · TTM

Operating CF $450.77M
Capex −$140.53M
Free cash flow $310.25M
Buybacks $66.71M
Dividends paid $37.03M
Shareholder yield 0.8%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

5.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$114.86 vs $403.32
Trades 3.5× above classic defensive value — priced for growth
Fundamentals through 2026-03-28 · computed by TickerWolf from SEC filings